Will Glucarpidase After Methotrexate Treatment for Bone Sarcoma Lead to Fewer Side Effects and Reduce Chemotherapy Delays?

NCT02022358 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

34

Enrollment

OTHER

Sponsor class

Stopped Recruitment almost complete, has been slow and challenging

Conditions

Osteosarcoma
Spindle Cell Sarcoma of Bone

Interventions

DRUG: Glucarpidase
DRUG: Methotrexate
DRUG: Folinic Acid

Sponsor

University College, London

Collaborators

[object Object]